Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Melanoma Research|June 1, 1995
Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcomeV A Flørenes, R Holm, O FodstadAnticancer Research|January 15, 1998
Expression of stromelysin-3 in medullary carcinoma of the breastR Holm, V A Flørenes, B Erikstein, et al.Cancer Research|January 15, 1994
Expression of the neuroectodermal intermediate filament nestin in human melanomasV A Flørenes, R Holm, O Myklebost, et al.Histopathology|July 17, 2001
Reduced expression of p21WAF1 is an indicator of malignant behaviour in anal carcinomasR Holm, E Skovlund, H Skomedal, et al.Cancer Genetics and Cytogenetics|December 1, 1994
The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomasA Forus, V A Flørenes, G M Maelandsmo, et al.The Journal of Pathology|December 18, 2001
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcomeV A Flørenes, G M Maelandsmo, R Faye, et al.The American Journal of Pathology|December 1, 1996
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesionsG M Maelandsmo, R Holm, O Fodstad, et al.Oral Diseases|November 25, 2003
COX-2 expression in striated muscle under physiological conditionsJ Sudbø, A Reith, V A Flørenes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanomaV A Flørenes, R S Faye, G M Maelandsmo, et al.Journal of the National Cancer Institute|September 7, 1994
MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene statusV A Flørenes, G M Maelandsmo, A Forus, et al.Pageof 3